1. Home >
  2. M&A >
  3. Stake Purchase >
  4. Japan >
  5. Medirom Invests In Japan Gene Medicine

Investment Summary

Medirom Invests In Japan Gene Medicine

On June 30, 2024, Medirom invested in healthcare services company Japan Gene Medicine

Investment Highlights
  • This is Medirom’s 1st transaction in the Healthcare Services sector.
  • This is Medirom’s 3rd transaction in Japan.

Investment Summary
Date 2024-06-30
Target Japan Gene Medicine
Sector Healthcare Services
Investor(s) Medirom
Deal Type Stake Purchase

Target

Japan Gene Medicine

Tokyo, Japan
Japan Gene Medicine is a company engaged in the prenatal diagnosis business, providing genetic testing and analysis, and the company does business with major private, public, and university hospitals. Japan Gene Medicine was founded in 2019 and is based in Tokyo, Japan.

Search 214,107 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Investor(S) 1

Investor

Medirom

Tokyo, Japan
Category Company
Founded 2000
Sector Business Services
Employees334
Revenue 8.3B USD (2024)
DESCRIPTION

Medirom is a healthcare general trading company that can provide comprehensive services from prevention to treatment, which provides the best combination of healthcare methods, products, and services to fit the user's lifestyle. Medirom was founded in 2000 and is based in Tokyo, Japan.

DEAL STATS #
Overall 3 of 3
Sector: Healthcare Services M&A 1 of 1
Type: Stake Purchase M&A Deals 1 of 1
Country: Japan M&A 3 of 3
Year: 2024 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2021-04-30 SAWAN

Japan

SAWAN is a relaxation salon operator.

Buy -
Mergr

Solution for

Product

Company

Legal